ADDITION OF PEGINTERFERON ALFA-2a INCREASES HBsAg DECLINE IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY: RESULTS FROM A MULTICENTER RANDOMIZED CONTROLLED TRIAL. (PAS STUDY)

被引：0
|
作者：
Farag, Mina S. [1 ,2 ]
Fung, Scott K. [1 ]
Van Campenhout, Margo [3 ]
Van Erpecum, Karel J. [4 ]
Wong, David K. H. [1 ]
Boonstra, Andre [5 ]
Verhey, Elke [3 ]
De Man, Robert A. [3 ]
Liem, Kin Seng [1 ,3 ]
Hansen, Bettina E. [1 ,6 ]
Janssen, Harry L. A. [1 ]
机构：
[1] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto Gen Hosp, Toronto, ON, Canada
[2] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[3] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[4] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands
[5] Erasmus Univ, Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[6] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
195
引用
收藏
页码：127A / 128A
页数：2
相关论文
共 50 条
  • [21] PROGRESSIVE DECLINE OF HBSAG TITERS IN LONG-TERM VIROLOGICAL RESPONDERS TO NUCLEOS(T)IDE ANALOGUE THERAPY FOR CHRONIC HEPATITIS B
    Iavarone, Massimo
    Lampertico, Pietro
    Vigano, Mauro
    Facchetti, Floriana
    Melotti, Silvia
    Lunghi, Giovanna
    Colombo, Massimo
    HEPATOLOGY, 2008, 48 (04) : 709A - 709A
  • [22] Effect of switching from nucleos(t)ide maintenance therapy to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomized trial
    Woo, Hyun Young
    Heo, Jeong
    Tak, Won Young
    Lee, Heon Ju
    Chung, Woo Jin
    Park, Jung Gil
    Park, Soo Young
    Park, Young Joo
    Lee, Yu Rim
    Hwang, Jae Seok
    Kweon, Young Oh
    PLOS ONE, 2022, 17 (07):
  • [23] COMBINATION THERAPY WITH PEGINTERFERON ALFA-2a AND A NUCLEOS(T)IDE ANALOGUE FOR HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS: RESULTS OF A LARGE, RANDOMISED, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Su, W. -W.
    Hsu, C. -W.
    Lee, C. -M.
    Peng, C. -Y.
    Chuang, W. -L.
    Kao, J. -H.
    Chien, R. -N.
    Chu, H. -C.
    Huang, Y. -H.
    Liaw, Y. -F.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S47 - S47
  • [24] Long-term clinical outcome of HBeAg-negative chronic hepatitis B patients who discontinued nucleos(t)ide analogues
    Manolakopoulos, Spilios
    Kranidioti, Hariklia
    Kourikou, Anastasia
    Deutsch, Melanie-Maria
    Triantos, Christos
    Tsolias, Chrysostomos
    Manesis, Emanuel K.
    Mathou, Nicoletta
    Alexopoulou, Alexandra
    Hadziyannis, Emilia
    Papatheodoridis, George
    LIVER INTERNATIONAL, 2021, 41 (01) : 48 - 57
  • [25] Limited Sustained Response and Lack of HBsAg Decline after Stopping Long-Term Nucleos(t)Ide Analogue Therapy in Hbeag Negative Patients with Chronic Hepatitis B: Results of a Prospective, Randomized, Open-Label Phase IV Trial
    Liem, Kin Seng
    Fung, Scott K.
    Wong, David K. H.
    Yim, Colina K.
    Noureldin, Seham
    Huang, Feng Fei
    Shah, Hemant A.
    Feld, Jordan J.
    Hansen, Bettina E.
    Janssen, Harry L. A.
    HEPATOLOGY, 2018, 68 : 165A - 165A
  • [26] Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss
    Zoutendijk, Roeland
    Hansen, Bettina E.
    van Vuuren, Anneke J.
    Boucher, Charles A. B.
    Janssen, Harry L. A.
    JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (03): : 415 - 418
  • [27] Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D
    Lampertico, Pietro
    Brunetto, Maurizia R.
    Craxi, Antonio
    Gaeta, Giovanni B.
    Rizzetto, Mario
    Rozzi, Antonella
    Colombo, Massimo
    Antonio, D.
    Andreone, P.
    Antonio, D.
    Brancaccio, G.
    Bronte, F.
    Bruzzone, L.
    Caccamo, G.
    Caccianotti, B.
    Calvaruso, V
    Chessa, L.
    Ciarallo, M.
    Coco, B.
    Colombatto, P.
    Cursaro, C.
    D'Aluisio, D.
    Demelia, L.
    Di Marco, V
    Dissegna, D.
    Invernizzi, F.
    Lenisa, I
    Lembo, T.
    Levrero, M.
    Marchese, V
    Mangia, G.
    Picciotto, A.
    Pierconti, S.
    Antonio, D.
    Raimondo, G.
    Rastelli, C.
    Rizzo, V
    Santantonio, T.
    Scuteri, A.
    Sorbello, O.
    Squadrito, G.
    Subic, M.
    Toniutto, P.
    Vukotic, R.
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (01) : 118 - 125
  • [28] HBSAG LOSS WITH TENOFOVIR DISOPROXIL FUMARATE PLUS PEGINTERFERON ALFA-2A IN CHRONIC HEPATITIS B: LONG-TERM RESULTS OF A GLOBAL RANDOMIZED CONTROLLED TRIAL
    Ahn, S. -H.
    Marcellin, P.
    Ma, X.
    Caruntu, F.
    Tak, W. Y.
    Elkhashab, M.
    Chuang, W. -L.
    Tabak, F.
    Mehta, R.
    Petersen, J.
    Corsa, A.
    Martins, E. B.
    Yee, L. J.
    Dinh, P.
    Subramanian, G. Mani
    Buti, M.
    Gaeta, G.
    Papatheodoridis, G.
    Flisiak, R.
    Chan, H. L. Y.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S524 - S525
  • [29] Incidence and predictors of flares after discontinuing nucleos (t)ide analogue therapy in HBeAg negative patients with chronic hepatitis B: Results from the randomized controlled STOP study
    Liem, Seng
    Fung, Scott
    Wong, David
    Yim, Colina
    Chen, Jenny
    Noureldin, Seham
    Feld, Jordan
    Hansen, Bettina
    Janssen, Harry
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E474 - E474
  • [30] Increased HBsAg Decline in Sustained Responders After Discontinuation of Long-term Nucleos(t)ide Analogue Therapy in Chronic Hepatitis B
    Chi, Heng
    Hansen, Bettina E.
    Abu-Amara, Mahmoud
    Yim, Colina
    Arends, Pauline
    Feld, Jordan J.
    van der Eijk, Annemiek A.
    de Knegt, Robert J.
    Wong, David K.
    Janssen, Harry L.
    HEPATOLOGY, 2014, 60 : 1105A - 1105A
12345